Texas Biomedical Research Institute (Texas Biomed), located in San Antonio, Texas, is an independent biomedical research institution, specializing in genetics and in virology and immunology. Texas Biomed is funded by government and corporate grants and contracts, and donations from the public. Founded in 1941 by Tom Slick as the Foundation of Applied Research, Texas Biomed became the Southwest Foundation for Research and Education in 1952, Southwest Foundation for Biomedical Research (SFBR) in 1982, and Texas Biomedical Research Institute on February 1, 2011. Located on a 200-acre (0.81 km) campus on the northwest side of San Antonio, Texas Biomed employs over 75 doctoral level biomedical scientists, including 28 principal investigators and 400 staff members. Focused on basic biomedical research, the Institute is divided into the Department of Genetics and the Department of Virology & Immunology. The Southwest National Primate Research Center, a part of Texas Biomed, is an international resource that provides specialized facilities and expertise in research with nonhuman primates to investigators from around the US and other countries. It maintains 4,000 nonhuman primates.
Some content from Wikipedia, licensed under CC BY-SA
Subscribe to rss feed
Texas Biomedical Research Institute scientists have identified a promising way to help fight tuberculosis (TB), a disease that still kills nearly 2 million people annually. The research focuses on a potential host-directed ...
Apr 5, 2023
1
97
A new software tool developed by Texas Biomedical Research Institute and collaborators can help scientists and vaccine developers quickly edit genetic blueprints of pathogens to make them less harmful.
Mar 15, 2023
0
52
A modified tuberculosis (TB) vaccine developed at Texas Biomed could help treat a form of bladder cancer, called non-muscle invasive bladder cancer, without strong side effects. Results in mouse models and human cells show ...
Aug 22, 2022
0
29
As part of ongoing efforts to make a live attenuated vaccine for COVID-19, Texas Biomedical Research Institute Professor Luis Martinez-Sobrido and his team developed a weakened, or attenuated, version of SARS-CoV-2 that does ...
Jul 21, 2022
0
7
Briefly blocking a key molecule when administering the only approved vaccine for tuberculosis vastly improves long-term protection against the devastating disease in mice, researchers from Texas Biomedical Research Institute ...
Mar 11, 2022
0
45
Two weeks makes a big difference in treating the animal version of HIV and latent tuberculosis, researchers from Texas Biomedical Research Institute, Southwest National Primate Research Center and colleagues report this month ...
Feb 15, 2022
0
158
What is going on at the single-cell level in the first days of SARS-CoV-2 infection in the lungs?
Feb 8, 2022
0
67
A Zika virus vaccine candidate is effective at preventing the Zika virus passing from mother to fetus in preclinical animal studies, according to a new study in the journal npj Vaccines.
Jan 27, 2022
0
58
A new study from Texas Biomedical Research Institute (Texas Biomed) and collaborators has identified a promising drug candidate to minimize uncontrolled, erratic muscle movements, called dyskinesia, associated with Parkinson's ...
Dec 1, 2021
0
123
As widely-anticipated decisions about COVID-19 vaccine boosters roll out from U.S. agencies today, insights from an independent study underscore why boosters are important for all adults.
Nov 19, 2021
0
10
